Background/Aims: Hypoxia leads to the development of neovascularization in solid tumor by regulating VEGF expression. Aromatic hydrocarbon receptor (AHR), a receptor for dioxinlike compounds, functions as a transcription factor through dimerization with hypoxiainducible factors 1β (HIF-1β) and inhibits the secretion of vascular endothelial growth factor (VEGF). The purpose of this study was to explore whether AHR can suppress hypoxiainduced VEGF production in prostate bone metastasis cells and repress neovascularization in endothelial progenitor cells (EPCs), and, if so, through what mechanisms. Methods: PC-3 or LNCaP cells induced angiogenesis was detected by Matrigel-based tube formation assay, mRNA expression levels was measured by qRT-PCR, VEGF secretion level was determined by ELISA assay, respectively. Results: AHR activation inhibits hypoxia-induced adhesiveness and vasculogenesis of EPCs induced by PC-3 or LNCaP cells under hypoxia. Moreover, AHR activation suppressed hypoxia-induced VEGF production in PC-3 and LNCaP cells (48 ± 14% in PC-3, p = 0.000; 41 ± 14% in LNCaP, p = 0.000) by attenuating HIF-1α and HIF-1β level that in turn diminished the angiogenic ability of EPCs in vitro. Furthermore, we found the mRNA level of hypoxia-inducible factors 1α (HIF-1α) (1.54 ± 0.13 fold in PC-3, p = 0.002, 1.62 ± 0.12 fold in LNCaP, p = 0.001) and HIF-1β (1.67 ± 0.23 fold in PC-3, p = 0.007; 1.75 ± 0.26 fold in LNCaP, p=0.008) were upregulated in prostate cancer bone metastasis PC-3 and LNCaP cell lines in response to hypoxia, and revealed that the regulation of VEGF by HIF-1α and HIF-1β was S. Huang and Y. Guo contributed equally to this work.
Introduction
Prostate cancer (PCa) is the most commonly diagnosed malignant tumor, accounting for the second leading cause of cancer-related deaths in western countries [1] , and once tumors metastasize to bone, they are virtually incurable and result in significant morbidity prior to a patient's death [2, 3] . Neovascularization not only is essential for primary tumor growth, but also facilitates tumor invasion and metastasis [4] . In cancer patients with metastasis, neovascularization-mediated progression of micrometastasis to lethal macrometastasis is the major cause of mortality [5] . In our previous study, we found that treatment of prostate cancer bone metastasis PC-3 cells by hypoxia enhances the migratory and capillary tube formation abilities of human bone marrow derived-endothelial progenitor cells (BM-EPCs) in vitro [6] . Moreover, hypoxia-induced pathological neovascularization was shown to mediate tumor cell dissemination, invasion and metastasis in a zebrafish tumor model [7] .
Hypoxia-inducible factors (HIFs) are essential components in regulating transcription of genes that mediate the response to hypoxia. It is reported that cancer cells often show increased levels of HIF-1α and HIF-2α, especially in aggressive tumor cells [8] [9] [10] . Dimerized with a constitutively expressed β-subunit, HIF-1α and HIF-2α regulate expression of target genes in response to hypoxia in different respects [11] . However, the roles of HIF-1α and HIF-2α in regulating neovascularization, in PCa bone metastasis under hypoxic conditions remain unclear.
HIF-1 is found overexpressed in various types of cancers and can modulate angiogenesis by regulating VEGF expression [12] . HIF-1 is a heterodimeric transcription factor consisting of two subunits: HIF-1α and HIF-1β, and HIF-1β is also known as aryl hydrocarbon receptor nuclear translocator (ARNT) [13] . Meanwhile, HIF-2α shows close sequence homology and similar regulatory properties as HIF-1α [14, 15] . HIF-1α is known to be a key regulator of angiogenesis in various types of cancer, and overexpression of HIF-1α is related with metastasis of human prostate cancer [16] [17] [18] [19] . Previous reports suggested that PI3K/Akt is a major cellular signaling hub that plays a key role in numerous cellular functions including proliferation, migration, metabolism, and survival [20] . PI3K regulate the formation of vascular system that is tightly correlated with HIF-1α expression [21] . Therefore, we thus examine that PI3K signaling is needed for HIF-1-mediated VEGF expression in PCa bone metastasis.
HIF-1β, also known as the aryl hydrocarbon nuclear translocator (ARNT), is the heterodimeric partner of HIF-1α that is involved in a number of cell signaling pathways such as the AHR signaling pathway. AHR belongs to the basic helix-loop-helix/per-HIF-1β-sim family of transcription factors. Previous studies show that AHR and HIF-1β might collaboratively regulate the carcinogenic process of PCa [22, 23] and AHR can inhibit prostate carcinogenesis and VEGF production in transgenic adenocarcinoma of the mouse prostate [24, 25] . A further study illustrates the role for AHR in cardiac and vascular development and homeostasis was set up by the generation of AHR-null mice [26] . However, whether AHR plays a role in hypoxia-induced vasculogenesis of BM-EPCs is not fully understood.
In our study, HIF-1α and HIF-1β was upregulated in response to hypoxia treatment that was associated with enhanced expression of VEGF in PCa bone metastasis PC-3 and LNCaP cell lines. AHR activation suppressed hypoxia-induced VEGF production in PC-3 and LNCaP cells by attenuating HIF-1α and HIF-1β level, and subsequently, reducing intercellular adhesion between PC-3 and EPCs, and diminished the tube formation capacity of EPCs. Moreover, we present evidence supporting that regulation of VEGF by HIF-1α and HIF-1β, but not HIF-2α, in response to hypoxia through phosphatidylinositol 3-kinase (PI3K) activation. These results provide new clues to understand the molecular mechanisms of the HIF pathway in the regulation of neovasculogenesis in PCa bone metastasis and show the possibility of developing novel therapeutics targeting tumor neovascularization.
Materials and Methods

Cell culture
The bone metastatic PCa cell line PC-3 and LNCaP cell lines were purchased from the American Type Culture Collection (ATCC; Manassas, VA), and maintained in F-12 medium (Hyclone) and RPMI 1640 medium (Gibco, Invitrogen) separately supplemented with 10% fetal bovine serum, 100 mg/ml streptomycin, and 100 units/mlpenicillin. For normoxia experiments, the PC-3 and LNCaP cells were cultured at 37˚C with 5% CO 2 /95% air in a humidified incubator, and for hypoxia experiments, the PC-3 and LNCaP cells were cultured at 37˚C with 5% CO 2 , 94% N 2 , and 1% O 2 in a multigas incubator (Juji Field, Tokyo, Japan).
BM-EPCs were isolated from bone marrow blood of male patients with lumbar degenerative diseases (age range, 48-81 years; mean age 53.8 ± 16.9 years) at the time of operation as previously report [6] . Informed consent was obtained from the patients, and all procedures were performed in accordance with the guidance and approval of a research Ethics Committee at the First Affiliated Hospital of Sun Yat-sen University (NO. 2008-55).
Cell-cell adhesion assay
To characterize the possible effect of hypoxia on cell-cell adhesion, PC-3 cells were grown overnight to a confluent monolayer. In addition, EPCs were treated as indicated for 48 h and fluorescence-labeled with calcein acetoxymethyl (AM) (Molecular Probes, Invitrogen, CA, USA) for 1 h at 37°C followed by washing with PBS. These cells were then plated onto the established cell monolayer (PC-3 cells). Attachment and spreading of the plated cells were monitored and recorded after 20 min by a fluorescence microscopy. Quantification of intercellular adhesion was performed by counting the number of cells per microscopic field of view that remained attached after three gentle washing steps with PBS.
BM-EPCs tube formation assay
The co-cultures on matrigel system was used to assess angiogenic capability of PC-3 and LNCaP cells. Briefly, PC-3 and LNCaP cells were embeded in 100 µL liquid matrigel and seeded into 96-well plates. After overnight incubation, 5 × 10 3 EPCs in 100 µL of the complete medium were introduced onto the top of the solidified PC-3 and LNCaP matrigel suspension. The co-cultures on matrigel were inspected and photographed at 18 h following the overlaid of EPCs under an inverted light microscope at 200× magnification. Five independent fields were detected for each well and the average number of tubes/field was calculated.
Small interference RNA (siRNA) transfection siRNA were designed using Invitrogen BOCK-iT RNAi designer and targeted to HIF-1α, HIF-1β, HIF-2α: Before transfections, 2 × 10 5 cells were seeded per well of 6-well plates for 24 h. After that, siRNAs were transfected with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Cellular levels of the mRNA specific for the siRNA transfection were checked by quantitative real-time RT-PCR (qRT-PCR), and all experiments were performed 48 h after transfection.
Quantitative Real-time PCR Total RNA was isolated from PC-3 and LNCaP cells using the Trizol reagent (Invitrogen) according to the manufacturer's instructions. cDNA was amplified under cycling conditions of 95°C for 3 min, followed by 40 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 60 s. Real-time PCR analysis was performed using the iQ5 Real Time PCR Detection System (Bio-Rad). Relative expression values of HIF-1α, HIF-1β, HIF-2α, VEGF, AHR and GAPDH from three independent experiments were calculated following the 2 -DDCt method of Schmittgen and Livak [27] .
Enzyme-Linked Immunosorbent Assay (ELISA) for VEGF
ELISA was performed using VEGF ELISA kit (Excell, Shanghai, China) as previously described [20] . Briefly, the supernatants of PC-3 and LNCaP cells were collected and detected by ELISA assay, according to the manufacturer's protocol. 50 µL of supernatants incubated with dilution buffer (50 µL/well) and incubation buffer (50 µL/well) at room temperature for 2 h in a 96-well plate. The 96-well plate was washed 4 times with wash buffer and incubated with biotin conjugate (100 µL/well) at room temperature for 1 h. After washing, stabilized chromogen (100 µL/well) was used to incubate in the dark for 30 min at room temperature. At the end, stop solution (100 µL/well) was used and the absorbance was detected at 450 nm.
Statistical analysis
Data were analyzed using a Student's t-test on SPSS 17.0 (SPSS, Inc., Chicago, IL, USA) Software, and One-way ANOVA was performed for comparing more than two groups. Each result was obtained from at least three independent experiments and the experimental data are presented as the means ± standard deviation from at least three individual experiments. p < 0.05 was considered statistically significant for all tests.
Results
AHR suppresses the adhesiveness and vasculogenesis of EPCs induced by PC-3 or LNCaP cells under hypoxia
Using a lentiviral transduction system, we successfully overexpressed the AHR in PC-3 and LNCaP cells (Fig. 1A) . Consequently, cells with high expression of AHR showed lower number of adherent cells and tubes on Matrigel under hypoxia as compared to control cells (Fig. 1E, 2A and 2E ). To further enlighten the role of HIF-1 on capillary tube formation of BM-EPCs, cells were silenced with HIF-1α, HIF-1β or HIF-2α by siRNA transfection. RT-PCR was performed to ensure adequate knocking down of HIF-1α, HIF-1β or HIF-2α (Fig. 1B, 1C  and 1D ). As shown in Fig. 1F, 2B and 2F, knockdown of HIF-1α or HIF-1β also dramatically decreased the ability of adhesion and tube formation by EPCs. In contrast, low expression of HIF-2α had no significant effect on intercellular adhesion and tube formation of EPCs.
The PI3K pathways are known for regulating cell growth, cell survival and endothelial cell angiogenesis [28] . In our study, the inhibition of PI3K with LY294002 significantly diminished the capacity of intercellular adhesion between PC-3 and EPCs, and lowered the capability of EPCs to form tubular network in vitro. Further study utilized VEGFR2 inhibitor DMH4 also showed suppressive effect on cell adhesion and angiogenesis, suggesting that PI3K signaling pathway may be involved in angiogenesis under hypoxic conditions (Fig. 1G,  2C and 2G).
AHR expression and activation inhibits hypoxia-induced VEGF expression in PC-3 and LNCaP cells
AHR was reported in the previous studies to participate in the inhibition of hypoxiainduced VEGF production and prostate carcinogenesis [24, 25] . Therefore we examined whether AHR signaling activation suppressed hypoxia-induced VEGF transcription in PC-3 and LNCaP cells. Consequently, hypoxia-induced VEGF expression was significantly declined in AHR transfected cells (Fig. 3A and 3C) . Furthermore, activation of the AHR signaling pathway by the specific AHR agonist 3-methylcholanthrene (3-MC) also efficiently suppressed hypoxia-induced VEGF mRNA transcription ( Fig. 3B and 3D) . The combined data supported that activation of AHR signaling repressed VEGF expression in PC-3 and LNCaP cells under hypoxic conditions.
HIF-1α and HIF-1β are required for hypoxia-induced VEGF expression
Previous studies have suggested that hypoxia stimulates HIF-1α and VEGF expression in PCa bone metastasis cell [29] . HIF-1β is an essential dimerization partner of HIF-1α to form an active transcription complex, which is able to regulate VEGF expression under hypoxia.
To further demonstrate the role of HIF-1α or HIF-1β in regulating hypoxia-induced VEGF expression in PC-3 and LNCaP cells, we used specific siRNA to silence their expression. As shown in Fig. 4A and 5A, mRNA expression of HIF-1α and HIF-1β were increased under hypoxia compared with normoxia. In particular, the HIF-1α/HIF-1β expression in PC-3 and LNCaP cells under hypoxic conditions was revealed to be inhibited when HIF-1α/HIF-1β was knocked down by siRNA. In addition, an increased transcriptional level of VEGF was confirmed under hypoxic conditions ( Fig. 4B and 5B). And the expression of VEGF in PC-3 and LNCaP cells under hypoxic conditions was revealed to be inhibited when the cells were knocked down by HIF-1α or HIF-1β ( Fig. 4C and 5C ). These results strongly suggested that HIF-1α and HIF-1β were required for hypoxia-induced VEGF expression.
HIF-2α does not directly regulate the expression of VEGF
HIF-1α and HIF-2α are considered to be potential targets for tumor therapy since they regulate the expression of genes that participate in the tumor cell survival, angiogenesis, and aggressiveness. To determine the contribution of HIF-2α to VEGF expression, mRNA expression of VEGF subject to hypoxia was examined in PC-3 cells. As shown in Fig. 6A , mRNA expression of HIF-2α was increased under hypoxia compared with normoxia. In particular, HIF-2α expression in PC-3 and LNCaP cells under hypoxic conditions was revealed to be declined when HIF-2α was knocked down by siRNA. In addition, the increased transcriptional level of VEGF was confirmed under hypoxic conditions. But the expression of VEGF was revealed to be not affected when cells were silenced with HIF-2α under hypoxic conditions ( Fig. 6B and 6C ). These results strongly suggested that compared with the heterodimer of HIF-1α and HIF-1β, HIF-2α was not required for hypoxia-induced VEGF expression.
PI3K regulates HIF-1α signaling and mediates hypoxia-induced VEGF expression
Cellular proliferation and survival require the involvement of phosphoinositide 3-kinase (PI3-K)/Akt pathways. And PI3K may act as an upstream regulator of HIF-1α expression in various tumor cells including PCa cells [30] [31] [32] [33] [34] [35] . Therefore, we hypothesized that PI3K signaling was required for HIF-1-mediated VEGF expression in PC-3 and LNCaP cells. tumorigenicity that expressed by prostate cancer at a high level [37, 38] . Indeed, antiangiogenic agents applying for anti-tumor therapies targeting VEGF has proven to be clinically efficacious [39] . In this study, we demonstrated that AHR activation inhibits hypoxia-induced adhesiveness and vasculogenesis of EPCs induced by PC-3 or LNCaP cells under hypoxia through targeting VEGF and HIF-1α expression. Mechanistically, we found that these effects involve the PI3K signaling pathway. Although HIF-2α was overexpressed under hypoxic conditions, it was found not significantly affect VEGF expression in PCa bone metastasis cell lines in the current study. The adhesion of circulating tumor cells to vascular endothelial cells is one of the key steps for metastasis because it can protect tumor cells from anoikis, fluid shear force, and attack from the immune system [40] . The results of the present study indicated that AHR remarkably suppressed hypoxia-induced heterotypic adhesion between EPCs and PC-3 cells, which implies that the decreased endothelial-PC-3 adhesion may contribute to the abridged angiogenic and metastatic effect exerted by AHR. Furthermore, the inhibition of endothelial-PC-3 adhesion after knockdown of HIF-1α and HIF-1β suggests those effects are HIF-1α and HIF-1β-dependent.
Recent studies have shown that EPCs contribute significantly to tumor growth and metastatisation [5, 41, 42] . Meanwhile, blood levels of EPCs tend to increase in cancer patients and has a strong association with the stage of malignant disease [43] . In our previous published papers, we found that treatment of PC-3 cells by hypoxia enhances the migratory and tube formation abilities of BM-EPCs in vitro [6] . Therefore, anti-angiogenic treatments targeting VEGF signaling in EPCs may facilitate anti-tumor effects in cancer patients [44] . In the present study, our data confirm that hypoxia significantly enhanced the tube formation of EPCs induced by PC-3 and LNCaP cells, which can be suppressed significantly by the VEGFR2 inhibitor DMH4. These results strongly suggest that hypoxia-induced VEGF expression play an important role in tube formation of EPC, and those effects are HIF-1α and HIF-1β-dependent. Furthermore, AHR also inhibited vasculogenesis of EPCs effectively through the crosstalk between HIF-1β, which is dependent on hypoxia-induced VEGF signaling pathways. In all, those results suggested a role of AHR as a tumor suppressor in PCa bone metastasis, that is similar to the effects previously reported in heart and breast cancer.
Ablation of AHR results in enhancement of ischemia-induced angiogenesis, which may be caused by an increased abundance and activity of the HIF-1-ARNT heterodimer. This effect is likely attributed to the associated enhancement of ischemia-induced VEGF expression [45] . Activation of AHR can inhibit prostate tumor metastasis in TRAMP mice [24] . Moreover, hypoxia-induced signaling is involved in AHR activity in breast cancer cells and hepatocarcinoma cells [46] . The results in the current work revealed that AHR, significantly inhibited the expression of VEGF both in PC-3 and LNCaP cells, and the activation of AHR facilitate the inhibition of VEGF induced by hypoxia, indicating that HIF-1β (ARNT) is a dimerization partner of HIF-1α in hypoxia-induced signaling as mentioned above. These results suggested that reciprocal crosstalk may exist between AHR and hypoxia signaling pathways as some reports mentioned [47, 48] . We hypothesized that AHR may undermine the interaction of HIF-1β with HIF-1α, and then inhibit hypoxia-induced VEGF expression in PCa bone metastasis cell lines.
HIF-1α and HIF-2α are the two major isoforms of the α-subunit in hypoxia, and share a high degree of sequence homology. Previous reports show that HIF-1α belongs to the PerArnt-Sim (PAS) family of basic helix-loop-helix transcription factors and dimerizes with HIF-1β to form the HIF-1 complex, which then potentiated VEGF expression by directly binding to the VEGF promoter in response to hypoxic conditions. Our data confirm that hypoxia significantly enhanced the expression of HIF-1α at protein level in PCa bone metastasis cell lines, which is consistent with previous evidence in LNCaP cells [49, 50] . The AHR, a ligand-activated transcription factor, also contains a basic helix-loop-helix motif and functions together with the AHR nuclear translocator (ARNT), which is identical to HIF-1β. Hypoxia-induced VEGF expression is HIF-1β-dependent and HIF-1β is needed for normal AHR functions. Similar to HIF-1α, our results showed that the expression of HIF-1β protein
